ANZ News
Emotional regulation could be the missing piece of the chronic pain treatment puzzle, says Australian researchers.
Also, TruScreen has secured a new distribution deal to reenter India.
Also, an AI-powered breath test for diagnosing silicosis has been developed in Sydney.
The training program from Edith Cowan University is expected to be released by early 2026.
Also, a new AI model potentially enhances endometrial cancer diagnosis by achieving near full accuracy in a latest study in Australia.
Also, Heidi Health has announced a new partnership for its New Zealand expansion.
Upcoming features include pre-chart summary creation.
Also, a new online platform providing rural doctors support and resources on allergies went live.
The funding, which is NRFC's first medical science investment, will help introduce the company's AI to more health facilities locally and abroad.
Also, a new mobile app in Australia tracks eyelid movement to detect sleep apnoea.